CSafe Global’s Board of Directors has named Patrick Schafer as the company’s new CEO. Schafer, previously CSafe’s Chief Financial Officer, steps into the role after serving as the company’s interim CEO since September.
CSafe Global, the leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals and the fast-growing cell and gene market, announced that Patrick Schafer has been named as the company’s new Chief Executive Officer.
Bill Mitchell, Chairman of PCI Pharma Services and a CSafe Global board member made the announcement to CSafe Global employees at the company’s headquarters and via video conference to its more than 200 employees worldwide. Mitchell had this to say: “Mr. Schafer’s unmatched knowledge and understanding of the industry and the CSafe organization, along with the exceptional rapport he’s built with the team during his 8-year tenure will help him lead CSafe to new levels of success. The entire board believes in this business and we are confident that Mr. Schafer will continue to drive growth and deliver excellent products and service to our customers.”
Schafer began his career at CSafe in 2012 as the Chief Financial Officer and has been serving as the interim CEO since September 2019. A dual U.S. and European citizen, Mr. Schafer has broad international experience having spent part of his career living and working in Europe.
“CSafe is an extraordinary company – one that I am honored to have the opportunity to lead,” said Schafer. “We have the best products in the industry, the best service and support, and the best team of innovative thinkers in our space. I have no doubt CSafe will continue to be the premier provider of cold chain shipping solutions and I am thrilled to help our entire team around the world work toward our goals.”
With the executive team now in place, the industry can expect to see much more from CSafe in the coming months and years. Schafer added, “We’ve made significant additions to our team and have rapidly expanded our active container fleet. We have an unrivaled global footprint and are eager to share our world-class cell and gene solutions and our new artificial intelligence platform. We are poised to not only fulfill current customer demand, but also provide exceptional solutions well into the future.”
